The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Distinct MET alterations to induce a common phenotype and to define a MET-driven subset of papillary RCC: Results from the Cancer Genome Atlas (TCGA) Kidney Renal Papillary (KIRP) Working Group.
 
Laurence Albiges
Consulting or Advisory Role - Amgen; Novartis; Pfizer; Sanofi
Research Funding - novartis (Inst); pfizer (Inst)
 
Bradley Murray
No Relationships to Disclose
 
Angela Brooks
No Relationships to Disclose
 
Andrew Cherniack
No Relationships to Disclose
 
Alice Berger
No Relationships to Disclose
 
Chad J. Creighton
No Relationships to Disclose
 
Christopher Ricketts
No Relationships to Disclose
 
Donald P. Bottaro
No Relationships to Disclose
 
Ramaprasad Srinivasan
No Relationships to Disclose
 
Laura S. Schmidt
No Relationships to Disclose
 
Matthew Meyerson
No Relationships to Disclose
 
Paul Spellman
No Relationships to Disclose
 
W. Marston Linehan
No Relationships to Disclose
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer